Bliss GVS Pharma Limited Overview
Pro stress-test →Bliss GVS Pharma Limited, incorporated in 1984, is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups. The company is the world's largest manufacturer of suppositories and pessaries with a diversified portfolio serving domestic and international markets.
Strategic Profile
Pro stress-test →The company manufactures, markets, and exports over 150 branded formulations across 60+ therapeutic segments, including anti-malarial, anti-fungal, anti-bacterial, antibiotic, anti-inflammatory, contraceptive, and anti-diabetic. The company is almost debt free, providing financial flexibility, though the company has delivered a poor sales growth of 3.27% over past five years.
Competitive Landscape
Pro stress-test →Bliss GVS operates in the specialty pharmaceutical segment, competing with major Indian pharma companies like Sun Pharma, Cipla, and Lupin, and international players in generic formulations. Its competitive advantage lies in specialized manufacturing capabilities for suppositories and pessaries, areas where it holds global leadership. However, it faces pressure from larger generics manufacturers with broader portfolios and stronger R&D capabilities.
Industry Context
Bliss GVS Pharma Limited operates in Pharmaceutical Manufacturing - Specialty & Generic.
Key facts
Founded: 1984 · Headquarters: Mumbai, India · Revenue: ₹810 Cr (FY2024, ~$97M USD) · Market cap: ₹2,231 Cr (~$268M USD)